Van Oekelen D, Megens A, Meert T, Luyten W H M L, Leysen J E
Discovery Research, Janssen Research Foundation, Beerse, Belgium.
Behav Pharmacol. 2002 Jul;13(4):313-8. doi: 10.1097/00008877-200207000-00008.
We distinguished the functions of the different 5-hydroxytryptamine-2 (5-HT(2)) receptor (5-HT(2)R) subtypes in the tryptamine-induced 5-HT syndrome in rats using (1) the 5-HT(2A)R antagonist R93274 (N-[(3-p-fluorophenyl-1-propyl)-4-methyl-4-piperidinyl]-4-amino-5-iodo-2-methoxybenzamide), the 5-HT(2A/C)R antagonist R99647 (2-(dimethylaminomethyl)2,3,3a,8-tetrahydrodibenzo[c,f]isoxazolo[2,3-a]azepine), the 5-HT(2B/C)R antagonist SB-242084 (6-chloro-5-methyl-1-[[2-[(2-methyl-3-pyridyl)oxy]-5-pyridyl]carbamoyl]-indoline), and several 5-HT(2)R antagonists (ketanserin, risperidone, pipamperone and mianserin); and (2) chronic 5-HT(2)R activation by 1-(2,5-dimethoxy-4-methylphenyl)-2-aminopropane (DOM). In contrast to SB-242084, the selective 5-HT(2A)R antagonist R93274 as well as the non-selective 5-HT(2A)R antagonists (R99647, ketanserin, risperidone, pipamperone and mianserin) significantly inhibited tryptamine-induced forepaw treading and tremors, and reversed peripherally mediated cyanosis into hyperaemia; only the 5-HT(2A/C)R antagonists R99647 and mianserin inhibited the tryptamine-induced hunched back. Intermittent DOM administration (intravenously every 48 h for 12 days) did not change the centrally mediated tryptamine-induced forepaw treading, tremors and hunched back at 1, 4 or 7 days after the last DOM pretreatment. The DOM-induced head twitch response, measured immediately after every DOM injection, was not affected. In contrast, peripherally mediated cyanosis was reversed into hyperaemia in 75, 11 and 20% of all pretreated rats at 1, 4 and 7 days, respectively, after the last DOM administration. Taken together, these finding suggest that central 5-HT(2A)Rs mediate tryptamine-induced forepaw treading and tremors, that peripheral 5-HT Rs mediate tryptamine-induced cyanosis, and that 5-HT(2A)Rs mediate tryptamine-induced hunched back. Peripheral 5-HT(2C)Rs are more sensitive to desensitization after intermittent treatment with an agonist than central 5-HT(2A)Rs.
我们使用以下方法区分了不同5-羟色胺-2(5-HT(2))受体(5-HT(2)R)亚型在色胺诱导的大鼠5-HT综合征中的功能:(1)5-HT(2A)R拮抗剂R93274(N-[(3-对氟苯基-1-丙基)-4-甲基-4-哌啶基]-4-氨基-5-碘-2-甲氧基苯甲酰胺)、5-HT(2A/C)R拮抗剂R99647(2-(二甲基氨基甲基)2,3,3a,8-四氢二苯并[c,f]异恶唑并[2,3-a]氮杂卓)、5-HT(2B/C)R拮抗剂SB-242084(6-氯-5-甲基-1-[[2-[(2-甲基-3-吡啶基)氧基]-5-吡啶基]氨基甲酰基]-吲哚)以及几种5-HT(2)R拮抗剂(酮色林、利培酮、匹泮哌隆和米安色林);(2)通过1-(2,5-二甲氧基-4-甲基苯基)-2-氨基丙烷(DOM)进行慢性5-HT(2)R激活。与SB-242084不同,选择性5-HT(2A)R拮抗剂R93274以及非选择性5-HT(2A)R拮抗剂(R99647、酮色林、利培酮、匹泮哌隆和米安色林)显著抑制了色胺诱导的前爪踏地和震颤,并将外周介导的发绀转变为充血;只有5-HT(2A/C)R拮抗剂R99647和米安色林抑制了色胺诱导的弓背。间歇性给予DOM(每48小时静脉注射一次,共12天)在最后一次DOM预处理后的1、4或7天,并未改变中枢介导的色胺诱导的前爪踏地、震颤和弓背。每次注射DOM后立即测量的DOM诱导的头部抽搐反应未受影响。相比之下,在最后一次给予DOM后的1、4和7天,分别有75%、11%和20%的所有预处理大鼠外周介导的发绀转变为充血。综上所述,这些发现表明中枢5-HT(2A)Rs介导色胺诱导的前爪踏地和震颤,外周5-HT Rs介导色胺诱导的发绀,并且5-HT(2A)Rs介导色胺诱导的弓背。外周5-HT(2C)Rs在间歇性用激动剂治疗后比中枢5-HT(2A)Rs对脱敏更敏感。